Literature DB >> 2240897

Emergence of recreational drug abuse as a major risk factor for stroke in young adults.

D A Kaku1, D H Lowenstein.   

Abstract

OBJECTIVE: To investigate the clinical and epidemiologic relations between recreational drug abuse and stroke in young persons.
DESIGN: A case-control study based on medical records.
SETTING: San Francisco General Hospital, a 400-bed municipal hospital. PATIENTS: Consecutive sample of 214 patients aged 15 to 44 years, admitted between 1979 and 1988 with a diagnosis of ischemic or hemorrhagic stroke. An equal number of control patients admitted with diagnoses of status asthmaticus, acute appendicitis, or acute cholecystitis were matched to stroke patients by age, sex, and year of hospitalization.
MEASUREMENTS AND MAIN RESULTS: Seventy-three patients with stroke (34%) were drug abusers compared with 18 (8%) of the controls. In 47 patients with stroke, temporal proximity of drug administration (n = 34) or infectious endocarditis (n = 13) suggested a direct association between drug abuse and stroke. After controlling for other identifiable stroke risk factors, the estimated relative risk for stroke among drug abusers compared with that among non-drug abusers was 6.5 (95% CI, 3.1 to 13.6), and this increased to 49.4 (CI, 6.4 to 379.0) for those patients whose symptoms began within 6 hours of drug administration. Among patients less than 35 years of age, drug abuse was the most commonly identified potential predisposing condition (47%), and it was the only condition with a significantly elevated relative risk for stroke (11.7; CI, 3.2 to 42.5). Further, a substantial rise in the proportion of drug-related strokes was observed in the last 3 years of the study (31% in 1986 to 1988, compared with 15% in 1979 to 1985, P = 0.008). Cocaine, especially recently, was the drug used most frequently in drug-related strokes.
CONCLUSION: In an urban population such as ours, recreational drug abuse appears to be a prominent and growing risk factor for strokes in young adults.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2240897     DOI: 10.7326/0003-4819-113-11-821

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  28 in total

1.  Misuse of ecstasy.

Authors:  R N De Silva; D P Harries
Journal:  BMJ       Date:  1992-08-01

Review 2.  Anesthetic management of the chemically dependent patient.

Authors:  T J Pallasch
Journal:  Anesth Prog       Date:  1992

Review 3.  Drug abuse and stroke.

Authors:  Ana Catarina Fonseca; José M Ferro
Journal:  Curr Neurol Neurosci Rep       Date:  2013-02       Impact factor: 5.081

Review 4.  Childhood arterial ischemic stroke: a review of etiologies, antithrombotic treatments, prognostic factors, and priorities for future research.

Authors:  Courtney A Lyle; Timothy J Bernard; Neil A Goldenberg
Journal:  Semin Thromb Hemost       Date:  2011-12-20       Impact factor: 4.180

5.  Cocaine Use and Risk of Ischemic Stroke in Young Adults.

Authors:  Yu-Ching Cheng; Kathleen A Ryan; Saad A Qadwai; Jay Shah; Mary J Sparks; Marcella A Wozniak; Barney J Stern; Michael S Phipps; Carolyn A Cronin; Laurence S Magder; John W Cole; Steven J Kittner
Journal:  Stroke       Date:  2016-03-10       Impact factor: 7.914

6.  Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  James F Meschia; Cheryl Bushnell; Bernadette Boden-Albala; Lynne T Braun; Dawn M Bravata; Seemant Chaturvedi; Mark A Creager; Robert H Eckel; Mitchell S V Elkind; Myriam Fornage; Larry B Goldstein; Steven M Greenberg; Susanna E Horvath; Costantino Iadecola; Edward C Jauch; Wesley S Moore; John A Wilson
Journal:  Stroke       Date:  2014-10-28       Impact factor: 7.914

7.  One-year medical outcomes and emergency department recidivism after emergency department observation for cocaine-associated chest pain.

Authors:  Rebecca Cunningham; Maureen A Walton; Jim Edward Weber; Samantha O'Broin; Shanti P Tripathi; Ronald F Maio; Brenda M Booth
Journal:  Ann Emerg Med       Date:  2008-09-27       Impact factor: 5.721

8.  Clinical pharmacology and vascular risk.

Authors:  G Silvestrelli; F Corea; S Micheli; A Lanari
Journal:  Open Neurol J       Date:  2010-06-15

9.  Cerebrovascular complications of methamphetamine abuse.

Authors:  Emily L Ho; S Andrew Josephson; Han S Lee; Wade S Smith
Journal:  Neurocrit Care       Date:  2009-01-09       Impact factor: 3.210

10.  Current research on the epidemiology, medical and psychiatric effects, and treatment of methamphetamine use.

Authors:  Richard A Rawson
Journal:  J Food Drug Anal       Date:  2013-12       Impact factor: 6.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.